In this episode of Diabetic Foot Files, Dr. G explores how existing medications — from metformin and insulin to statins, fentanyl, sildenafil, doxycycline and nitric oxide donors — are being repurposed to help heal stubborn diabetic foot ulcers. We review the biology behind each drug, early clinical evidence, and why topical formulations may offer targeted benefits with minimal systemic exposure.
Listeners will learn which agents show the strongest signals (topical insulin, topical metformin, topical statins), which remain promising but mixed (topical phenytoin), and how repurposed therapies fit as adjuncts to standard wound care rather than replacements. Practical takeaways include safety considerations, off-label use discussions, and the need for larger trials.
Fler avsnitt av Diabetic Foot Files
Visa alla avsnitt av Diabetic Foot FilesDiabetic Foot Files med Diabetic Foot Files finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
